Abstract
The Efficacy and Safety of Continued Hydroxyurea Therapy Versus Switching to Ruxolitinib in Patients with Polycythemia Vera: A Randomized, Double-Blind, Double-Dummy, Symptom Study (RELIEF)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have